USPTO serial 86300247
ONCOBIOME
Reviewed by CopyMark Law Group
Status 601
- Filing date
- Status date
- Registration date
- —
- Examiner
- ULRICH, NANCY G
- Law office
- TMO LAW OFFICE 113 - EXAMINING ATTORNEY ASSIGNED
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ONCOBIOME?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Heather E Balmat
HEATHER E BALMAT BALMAT LAW PLLC977 SEMINOLE TR#342CHARLOTTESVILLE, VA 22901Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | microbial preparations for pharmaceutical, veterinary and medical purposes, namely, microbial preparations for use as tumor suppressing agents, immuno-suppressing agents, immuno-stimulating agents, and anti-cancer agents; dietary supplements, nutritional supplements, nutraceuticals for use as dietary supplements, food supplements, nutritionally fortified vegetable-based food, beverages, and nutritional food bars, all of the foregoing containing microorganisms for medical, therapeutic, or preventative purposes; therapeutic pharmaceuticals containing microorganisms for medical and veterinary use for the treatment and prevention of pre-neoplastic lesions, neoplasms, tumors, cancers, and metastases; therapeutic pharmaceuticals containing derivatives of microorganisms for medical and veterinary use for the treatment and prevention of pre-neoplastic lesions, neoplasms, tumors, cancers, and metastases; pharmaceutical, veterinary and medical preparations and substances, namely, anti-microbial preparations and substances, anti-bacterial, anti-fungal, anti-viral, and anti-protist preparations and substances, all for the treatment of cancer, cancer symptoms, cancer-related diseases, and side-effects of cancer therapies; anti-cancer preparations and substances; preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals, namely, combination preparations containing in majority part antimicrobial preparations and lesser amounts of microbial preparations and anti-cancer preparations for use as a preservative; pharmaceutical preparations and substances for the treatment of cancer, namely, microbial and anti-microbial preparations for veterinary and medical use; anti-cancer preparations for use in treating cancer symptoms, cancer-related diseases, and side-effects of cancer therapies; pharmaceutical preparations for the treatment of infectious diseases and cancer, namely, combination preparations of anti-cancer agents, microbial preparations and anti-microbial preparations; diagnostic kits for diagnosing disease, determination of likelihood of disease, prognosis of responsiveness to therapy and/or patient prognosis comprised of diagnostic reagents and buffers for the detection of microbes, viral, bacterial, fungal, and parasitic or non-parasitic protist infections, inflammation, and biomarkers associated with pre-neoplastic lesions, neoplasms, tumors, cancers, or metastases; preparations for detecting mutations in genes for medical purposes as used in the collection of large-scale genomic, metagenomic, proteomic, transcriptomic, epigenetic, and metabolomic medical data and related clinical data | ACTIVE | — |
| 009 | scientific, analytical, and statistical computer software for creating and managing databases containing genomic, metagenomic, proteomic, transcriptomic, epigenetic, and metabolomic data derived from patient clinical care information and medical research data; computer software for analyzing and creating statistical models derived from patient clinical care information and medical research data in the nature of genomic, metagenomic, proteomic, transcriptomic, epigenetic, and metabolomic data | ACTIVE | — |
| 010 | medical diagnostic instruments for screening, assessing, and determining appropriate courses of treatment in relation to pre-neoplastic lesions, neoplasms, tumors, cancers and metastases | ACTIVE | — |
| 042 | electronic data storage services, namely, electronic storage of large-scale genomic, metagenomic, proteomic, transcriptomic, epigenetic, and metabolomic data and related clinical data for treatment and diagnostic purposes; database, computer-readable program and software development services, namely, development of scientific, analytical, and statistical software and related databases for use in conjunction with genomic, metagenomic, proteomic, transcriptomic, epigenetic, and metabolomic data gathered from patient clinical care information and medical research data; scientific, chemical, biochemical and microbiological research; scientific research in the field of genetics and genetic engineering of microbes; scientific research in the field of genetic and molecular tests, including tests for microbial populations in vertebrate samples; research and development of therapeutic pharmaceuticals, consumer medical products, diagnostic equipment and prognostic tools consisting of genetically engineered microorganisms, combinations of microorganisms, and individually selected microorganisms for treatment and prevention of pre-neoplastic lesions, neoplasms, tumors, cancers and metastases | ACTIVE | — |
| 044 | medical clinics; veterinary dentistry; behavioural analysis for medical purposes; genetic testing for medical purposes; collection and preservation of human blood for medical purposes; medical diagnostic testing for assessing pre-neoplastic lesions, neoplasms, tumors, cancers, or metastases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by EVELO THERAPEUTICS, INC.
- Other trademarks owned by VL28, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ONCOBIOME
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 2, 2017 | MAB1 | ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT | — |
| Oct 2, 2017 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| Sep 21, 2017 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Sep 21, 2017 | EXDM | EXPARTE APPEAL DISMISSED AS MOOT | — |
| Jul 21, 2017 | GEA1 | NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED | — |
| Jul 21, 2017 | GECD | ACTION DENYING REQ FOR RECON E-MAILED | — |
| Jul 21, 2017 | CNCF | ACTION CONTINUING FINAL - COMPLETED | — |
| Jul 3, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 3, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 29, 2017 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jun 29, 2017 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Jun 29, 2017 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Jun 29, 2017 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Dec 29, 2016 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Dec 29, 2016 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 29, 2016 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 6, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 5, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 5, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 3, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 3, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 3, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 13, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 13, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 13, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 13, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 13, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 13, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 4, 2015 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Oct 26, 2015 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 26, 2015 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 23, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 22, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 22, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 22, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 22, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 22, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 1, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 1, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 30, 2015 | ALIE | ASSIGNED TO LIE | — |
| Mar 21, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 2, 2015 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 2, 2015 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 23, 2014 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 23, 2014 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 23, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 16, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 19, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |